Catherine Eckford2023-02-14T18:05:28
The global highly potent active pharmaceutical ingredient (HPAPI) market is expected to reach $34.04 billion in 2026, a report has predicted.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-10-22T14:00:00
Sponsored by Bruker
2026-06-16T13:00:00
Sponsored by USP
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2026-06-15T07:55:00
Sponsored by Octave, Adam Cross
2025-12-11T13:32:00
Sponsored by Hexagon
2025-09-19T15:46:00
Sponsored by ACCI, European Pharmaceutical Review
Site powered by Webvision Cloud